Creatinine, a muscle-derived kidney marker
Creatinine is a small waste molecule made when your muscles use creatine for energy. It forms at a steady pace linked to muscle mass as creatine and phosphocreatine break down in skeletal muscle, then enters the bloodstream. The body doesn’t use creatinine; it is transported to the kidneys and eliminated in urine. A blood creatinine test measures how much of this muscle‑derived waste is circulating at a given moment (creatine/phosphocreatine, endogenous production).
Because production is relatively constant and the kidneys are the main exit route, the blood level of creatinine reflects how well the kidneys are filtering the blood. In practice, it serves as a convenient marker of kidney filtration capacity (glomerular filtration rate, GFR) and is used to calculate an estimated GFR (eGFR). Small amounts can be secreted by kidney tubules (proximal tubular secretion), but filtration by the glomeruli is the dominant path. In short, blood creatinine is the body’s running indicator of muscle metabolism products passing through the kidney’s filter—useful for gauging overall kidney function.
Why creatinine is the backbone of kidney screening
Creatinine is a waste product made by working muscle and cleared almost entirely by the kidneys. Because production is steady and removal depends on filtration, its blood level is a practical window into how well your kidneys are cleaning the blood and, secondarily, how much muscle you carry—two core determinants of whole‑body homeostasis.
Big picture: creatinine anchors estimated GFR and pairs with urine albumin and blood urea nitrogen to map kidney and cardiovascular risk. Persistently high levels forecast complications like hypertension, anemia, bone‑mineral disorders, and heart disease, while very low levels can mark frailty.
Interpreting low, normal, and high creatinine
Typical values sit lower in women than men and are lowest in children and teens; pregnancy drives values down further. For any individual, a stable result near the middle of the lab’s range is generally expected, and trends over time matter more than a single number.
When values run low, it often reflects reduced muscle mass from aging, inactivity, malnutrition, or chronic illness; severe liver disease can also lower production. People may notice weakness, fatigue, or unintended weight loss. In pregnancy, a lower value is normal due to higher kidney blood flow. Very low levels in older adults can signal frailty, with implications for balance, glucose handling, and resilience to illness.
When values are high, kidneys are commonly filtering less—whether from chronic kidney disease, sudden injury, obstruction, or severe dehydration. Symptoms can include swelling, high blood pressure, fatigue, nausea, itch, sleep disturbance, and muscle cramps as electrolytes shift. Muscular individuals or recent strenuous exercise can push levels up modestly; in pregnancy, even small rises are concerning.
Diet, muscle, and meds that move creatinine
Notes: Interpretation varies with age, sex, body size, and pregnancy. Recent cooked meat, creatine intake, vigorous exercise, and some drugs can transiently raise it. Assays differ slightly. Creatinine is most appropriate read with estimated GFR equations and, when needed, cystatin C.
Putting your creatinine number in context
A creatinine blood test measures creatinine, a waste from muscle energy use, in the blood. Because muscle makes it steadily and kidneys clear it by filtration, the level reflects muscle mass and glomerular filtration rate (GFR). Filtration supports fluid, electrolytes, acid–base balance, blood pressure control, toxin clearance, and therefore energy and cognition.
Low values usually reflect low muscle mass or increased filtration. They are typical in children, smaller-bodied adults, females, and during pregnancy (physiologic hyperfiltration). They also occur with muscle loss or low production (frailty, inactivity, malnutrition, advanced liver disease). This often signals limited protein reserves and can mask kidney impairment.
Being in range suggests stable muscle turnover and adequate filtration, with steady electrolytes, acid–base status, and blood pressure. For one’s sex and age, mid-range values often align with stable GFR; normal pregnancy sits lower, and very muscular people may sit higher within normal.
High values usually reflect reduced filtration from acute or chronic kidney dysfunction, volume depletion, or urinary obstruction. They also rise with greater input from muscle (large muscle mass, recent intense exercise, rhabdomyolysis, catabolic illness) or reduced tubular secretion/assay interference (trimethoprim, cimetidine, ketoacids). Higher levels signal accumulating wastes affecting energy, cognition, and electrolytes.
FAQs
It measures the concentration of creatinine in your blood and is used to estimate eGFR, a key indicator of kidney filtration.
It helps monitor kidney function, track trends, and add context to hydration, training, diet, medication use, and creatine supplementation.
Establish a baseline and trend with periodic testing. Consider more frequent testing during changes in training, hydration, diet, supplements, or medications, or when managing conditions like hypertension or diabetes.
Muscle mass, age, sex, hydration, recent strenuous exercise, high meat intake before testing, creatine supplements, pregnancy, severe liver disease, and certain medications (for example, NSAIDs, trimethoprim, cimetidine).
Fasting is usually not required. For consistent results, try to test at a similar time of day, avoid heavy meat intake and intense exercise in the 24 hours before testing, and note your usual hydration.
Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.
References
- Hosten, A. O. (1990). BUN and creatinine. In H. K. Walker, W. D. Hall, & J. W. Hurst (Eds.), Clinical methods: The history, physical, and laboratory examinations (3rd ed.). Butterworths. https://pubmed.ncbi.nlm.nih.gov/21250147/
- Gounden, V., Bhatt, H., & Jialal, I. (2024). Renal function tests. In StatPearls. StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/29939598/
- Inker, L. A., Eneanya, N. D., Coresh, J., Tighiouart, H., Wang, D., Sang, Y., Crews, D. C., Doria, A., Estrella, M. M., Froissart, M., Grams, M. E., Greene, T., Grubb, A., Gudnason, V., Gutierrez, O. M., Kalil, R., Karger, A. B., Mauer, M., Navis, G., ... Levey, A. S. (2021). New creatinine- and cystatin C-based equations to estimate GFR without race. The New England Journal of Medicine, 385(19), 1737-1749. https://doi.org/10.1056/NEJMoa2102953
- Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. L., Castro, A. F., 3rd, Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., & Coresh, J. (2009). A new equation to estimate glomerular filtration rate. Annals of Internal Medicine, 150(9), 604-612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 105(4S), S117-S314. https://doi.org/10.1016/j.kint.2023.10.018






































.avif)
